Catheter Precision, Inc. (VTAK)
USD 0.27
(0.33%)
USD 0.27
(0.33%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -78.11 Million USD | -189.75% |
| 2022 | -26.96 Million USD | 7.88% |
| 2021 | -29.26 Million USD | 18.84% |
| 2020 | -36.05 Million USD | 37.54% |
| 2019 | -57.73 Million USD | -85.27% |
| 2018 | -31.16 Million USD | -75.45% |
| 2017 | -17.76 Million USD | -323.06% |
| 2016 | -4.19 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -2.61 Million USD | -0.73% |
| 2024 Q2 | -2.71 Million USD | -3.86% |
| 2023 Q2 | -6.3 Million USD | 90.51% |
| 2023 Q1 | -66.48 Million USD | -709.3% |
| 2023 FY | -78.11 Million USD | -189.75% |
| 2023 Q4 | -2.59 Million USD | 4.87% |
| 2023 Q3 | -2.73 Million USD | 56.72% |
| 2022 Q1 | -5.5 Million USD | 33.41% |
| 2022 FY | -26.96 Million USD | 7.88% |
| 2022 Q4 | -8.21 Million USD | -71.75% |
| 2022 Q3 | -4.78 Million USD | 43.46% |
| 2022 Q2 | -8.46 Million USD | -53.73% |
| 2021 Q2 | -7.24 Million USD | -0.79% |
| 2021 Q4 | -8.26 Million USD | -11.77% |
| 2021 FY | -29.26 Million USD | 18.84% |
| 2021 Q3 | -7.39 Million USD | -2.1% |
| 2021 Q1 | -7.18 Million USD | 30.81% |
| 2020 FY | -36.05 Million USD | 37.54% |
| 2020 Q2 | -10.11 Million USD | -29.86% |
| 2020 Q4 | -10.38 Million USD | -33.66% |
| 2020 Q3 | -7.76 Million USD | 23.2% |
| 2020 Q1 | -7.79 Million USD | 20.83% |
| 2019 Q3 | -17.58 Million USD | -14.59% |
| 2019 Q2 | -15.34 Million USD | -2.63% |
| 2019 Q1 | -14.95 Million USD | 2.07% |
| 2019 FY | -57.73 Million USD | -85.27% |
| 2019 Q4 | -9.84 Million USD | 44.05% |
| 2018 Q2 | -8.39 Million USD | -211.7% |
| 2018 FY | -31.16 Million USD | -75.45% |
| 2018 Q4 | -15.27 Million USD | -217.73% |
| 2018 Q1 | -2.69 Million USD | 13.02% |
| 2018 Q3 | -4.8 Million USD | 42.72% |
| 2017 Q4 | -3.09 Million USD | -80.05% |
| 2017 Q2 | -11.28 Million USD | -579.29% |
| 2017 Q1 | -1.66 Million USD | 0.0% |
| 2017 Q3 | -1.71 Million USD | 84.76% |
| 2017 FY | -17.76 Million USD | -323.06% |
| 2016 FY | -4.19 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Perspective Therapeutics, Inc. | -15.18 Million USD | -414.55% |
| Electromed, Inc. | 6.58 Million USD | 1287.038% |
| Senseonics Holdings, Inc. | -75.6 Million USD | -3.328% |
| Xtant Medical Holdings, Inc. | -10.15 Million USD | -669.039% |